Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women.

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

Fast-growing commercial-stage diagnostics company numares AG today announced the worldwide launch of its new, software-based test insightLP™-S50, part of the Company’s lipoFIT® series for lipoprotein ...

Find out how lipoprotein(a) screening identifies women at long term cardiovascular risk and supports earlier prevention strategies for heart disease.

NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...

A study finds that a blood test that evaluates levels of three compounds — lipoprotein(a), C-reactive protein (a marker of inflammation), and “bad” LDL cholesterol — can accurately reveal heart ...

A single injection of the drug lepodisiran slashed a key heart risk factor, lipoprotein(a), by 94% for six months, offers hope for treating a genetic cause of heart disease.

Heart experts say that everyone should have their levels of lipoprotein (a) (Lp(a) measured routinely at least once in life, following research from one of the most populous EU countries, Poland, that ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Understanding your cholesterol test results in plain English Your doctor hands you a cholesterol report filled with ...